Retinoic Acid Early Transcript 1E (RAET1E) Antikörper
Kurzübersicht für Retinoic Acid Early Transcript 1E (RAET1E) Antikörper (ABIN7843504)
Target
Alle Retinoic Acid Early Transcript 1E (RAET1E) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Rabbit polyclonal antibody to RAET1E
-
Spezifität
- Recognizes endogenous levels of RAET1E protein.
-
Aufreinigung
- The antibody was purified by immunogen affinity chromatography.
-
Immunogen
- KLH-conjugated synthetic peptide encompassing a sequence within the Central region of human RAET1E. The exact sequence is proprietary.
-
-
-
-
Applikationshinweise
- WB (1/500 - 1/1000)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
-
- Retinoic Acid Early Transcript 1E (RAET1E)
-
Andere Bezeichnung
- RAET1E
-
Hintergrund
- LETAL, N2DL4, ULBP4, NKG2D ligand 4, N2DL-4, NKG2DL4, Lymphocyte effector toxicity activation ligand, RAE-1-like transcript 4, RL-4, Retinoic acid early transcript 1E
-
Gen-ID
- 135250
-
UniProt
- Q8TD07
Target
-